Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain

Epigenetics of cancer and changes in DNA modification in tumours ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain )

Strategies to improve the tolerability of treatment in patients with multiple...

Prof Michel Delforge - Catholic University, Leuven, Belgium

Strategies to improve the tolerability of treatment in patients with multiple myeloma ( Prof Michel Delforge - Catholic University, Leuven, Belgium )

Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012

Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter...

Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands, )

Best treatment for chronic lymphocytic leukaemia with 17p deletion

Prof Michael Keating - MD Anderson Cancer Center, Houston, USA

Best treatment for chronic lymphocytic leukaemia with 17p deletion ( Prof Michael Keating - MD Anderson Cancer Center, Houston, USA )

The involvement of rare cancer patients in clinical research

Jan Geissler - Co-founder of CML Advocates Network

The involvement of rare cancer patients in clinical research ( Jan Geissler - Co-founder of CML Advocates Network )

New drugs on the CML horizon; choosing the correct therapies

Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio...

New drugs on the CML horizon; choosing the correct therapies ( Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio - University of Turin, Italy, Dr Delphine Rea - Saint Louis Hospital, France )

The evolving landscape in the management of CML

Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio...

The evolving landscape in the management of CML ( Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio - University of Turin, Italy, Dr Delphine Rea - Saint Louis Hospital, France )

Maintenance therapy in multiple myeloma; the way forward

Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo...

Maintenance therapy in multiple myeloma; the way forward ( Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo - University Hospital of Torino, Italy, Dr Paul Richardson - Dana-Farber Cancer Institute, USA )

A new treatment paradigm in multiple myeloma

Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo...

A new treatment paradigm in multiple myeloma ( Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo - University Hospital of Torino, Italy, Dr Paul Richardson - Dana-Farber Cancer Institute, USA )

Advances with bendamustine in multiple myeloma from EHA 2012

Prof Philippe Rodon - General Hospital, Blois, France

Advances with bendamustine in multiple myeloma from EHA 2012 ( Prof Philippe Rodon - General Hospital, Blois, France )

Advances in multiple myeloma from EHA 2012

Prof Meletios Dimopoulos - Univeristy of Athens, Greece

Advances in multiple myeloma from EHA 2012 ( Prof Meletios Dimopoulos - Univeristy of Athens, Greece )

Advances in multiple myeloma from EHA 2012; bortezomib and beyond

Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology...

Advances in multiple myeloma from EHA 2012; bortezomib and beyond ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )

More from ecancer